Paul Jackson

Stocks Rise as Yields Fall and Markets Look Past New Risks

The market is starting to look through the headlines There is a lot for investors to worry about right now. Canada is preparing retaliatory tariffs on roughly $20 billion of U.S. goods. Consumer confidence just fell to its lowest level

Pentagon Expands Hunt for U.S. Critical Minerals Projects

Washington isn’t just making another critical-minerals list The U.S. government has spent years talking about how dependent the country is on foreign critical minerals. Now it is asking companies to show it what they can build. The Defense Industrial Base

RUM Group Lands a $13.7 Billion AI Deal. Now It Has to Deliver.

A $13.7 billion contract can change a company RUM Group shares jumped more than 8% in premarket trading after announcing a six-year AI infrastructure deal worth approximately $13.7 billion. The agreement calls for an unnamed U.S.-based cloud customer to purchase

Gold and Silver Surge as U.S. Debt Fears Return

Precious metals are back in the spotlight Gold and silver have come back to life in August, and this rally looks different from a simple bounce off the lows. Gold traded near $4,466 an ounce at the time of the

Micron’s $10 Billion AI Lab Is About More Than Memory

AI needs more than faster processors The AI race has spent years revolving around one word: GPUs. But the faster AI processors become, the more important everything around those processors becomes too. That is where Micron Technology is making its

The U.S. Just Stepped Back From a Canada Trade War

This is less about the tariffs than the trade war that didn’t happen Hours before new 50% tariffs were scheduled to hit certain Canadian imports, the U.S. Administration pulled them back. The pause lasts only three days, and Canada has

Marvell Jumps 6% as Google Makes a Much Bigger AI Bet

This is more than another AI chip contract Marvell Technology (Nasdaq: MRVL) jumped about 6% after revealing an unusual deal with Google that could eventually give the tech giant a major ownership stake in the chipmaker. Under the agreement, Google

3 Biotech Stocks That Could Move This Fall

Biotech is one of the few areas of the stock market where a company can look completely different by the end of a single trading day. A positive clinical trial can suddenly turn an overlooked drug into a serious commercial

Subscribe